(Reuters) – American Express Co said on Thursday it would ask its New York employees to work from office at least once a week, starting March 1, according to a memo posted on the company’s website. (Reporting by Sohini Podder...
READ MORE
Merck sees 2022 sales up nearly 20%, mostly on molnupiravir
By Michael Erman (Reuters) – Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new COVID-19 pill, molnupiravir. The drugmaker said sales of the...
READ MORE
Biogen’s 2022 forecast well below Street view on Alzheimer’s drug uncertainty
By Manas Mishra (Reuters) -Biogen Inc on Thursday forecast 2022 profit well below Wall Street estimates as sales of its new Alzheimer’s disease drug stall, and said it was considering deals of all sizes. The U.S. Centers for...
READ MORE
Eli Lilly pushes back timeline for Alzheimer’s drug application
By Leroy Leo (Reuters) – Eli Lilly and Co deferred its timeline to complete application for accelerated approval of its experimental Alzheimer’s drug, saying it expects such an approval to make little difference with...
READ MORE
Why Biden has eased up on Facebook over COVID misinformation
By Nandita Bose WASHINGTON (Reuters) – When U.S. President Joe Biden accused Facebook of “killing people” by spreading vaccine lies in July, many experts and researchers hoped it marked the beginning of a White House...
READ MORE
Roche sees slower 2022 sales growth as COVID tests demand eases
By Ludwig Burger (Reuters) -Swiss drugmaker Roche said on Thursday sales growth would slow this year as it braces for less demand for its COVID-19 medicines and tests, expecting immunity against the novel coronavirus to prevail in the...
READ MORE